NCT03958136 - Clinico-biological Data Collection Study of Metastatic Breast Cancer | Biotech Hunter

Enrollment

289

Participants

Timeline

Start Date

December 24, 2018

Primary Completion Date

December 24, 2035

Study Completion Date

December 30, 2036

Conditions

Breast Cancer

Interventions

PROCEDURE

Metastasis biopsy

Metastasis biopsy will be performed for multi-omic analysis

BIOLOGICAL

Biomarkers blood, urine and microbiota samples

Biomarkers blood, urine and microbiota samples for multi-omic analysis

BEHAVIORAL

Patient Reported Outcome (PRO)

Patient Reported Outcome (PRO) will be collected throughout the study duration to assess quality of life, anxiety, depression distress, physical activity and food habits.

Trial Locations (2)

44805

Institut de cancerologie de l'Ouest, Saint-Herblain

49055

Institut de Cacerologie de l'ouest - site Paul Papin, Angers